The ARCoV vaccine, developed by the Academy of Military Medical Sciences (AMMS), Suzhou Abogen Biosciences and Walvax Biotechnology, is being tested in an international Phase III trial

The directive increases pressure on authorities scrambling to keep pace with a deluge of new infections in the financial hub

Measures to control surging raw material costs weighed on producer prices amid steady falls in factory-gate price inflation from October's 26-year high

The company will "explore partnerships in providing accurate, affordable and accessible cancer early detection to the Hong Kong and Greater Bay Area communities"

The study finds that demographic trends alone will result in an overall 15% increase in the demand for long-term assets from 2020 to 2049

The adjustments to its investments, revealed in a Securities and Exchange Commission filing, reflect investor concerns about the Chinese tech sector

The deal combines Arch Capital’s experience in opportunistic and value-added strategies with Manulife’s $2.9 billion in assets around the region

Xu Weiping, the businessman responsible for developing the Royal Albert Docks in east London, is also embroiled in a legal dispute in Britain

FDI into the service industry amounted to 82.3 billion yuan last month, up 12.2% year on year, while inflows to high-tech industries surged 26.1%

Travel giant will allow staff to work away from the office for two days a week - the first large tech company in China to allow such a policy. Boss James Liang said it will be good for morale

Volkswagen's Audi and its Chinese state-owned partner FAW Group have won approval to start building their $3.3bn EV plant in Changchun city in the northeast in April.

A Zhenro Sept 2024 exchange-traded bond slumped more than 25%, triggering a trading suspension, while onshore bonds issued by units of Logan, R&F, Shimao and Ronshine also fell